Show simple item record

dc.contributor.authorGallego, Xabier
dc.contributor.authorMurtra, Patricia
dc.contributor.authorZamalloa Echevarría, Teresa ORCID
dc.contributor.authorCanals, Josep Maria
dc.contributor.authorPineda Ortiz, Joseba Gotzon ORCID
dc.contributor.authorAmador Arjona, Alejandro
dc.contributor.authorMaldonado, Rafael
dc.contributor.authorDierssen, Mara
dc.date.accessioned2013-11-07T12:05:41Z
dc.date.available2013-11-07T12:05:41Z
dc.date.issued2010-02-22
dc.identifier.citationFrontiers in Behavioral Neuroscience 3(60) : 1-14 (2010)es
dc.identifier.issn1662-5153
dc.identifier.urihttp://hdl.handle.net/10810/10855
dc.description.abstract[EN] Panic disorder is a highly prevalent neuropsychiatric disorder that shows co-occurrence with substance abuse. Here, we demonstrate that TrkC, the high-affinity receptor for neurotrophin-3, is a key molecule involved in panic disorder and opiate dependence, using a transgenic mouse model (TgNTRK3). Constitutive TrkC overexpression in TgNTRK3 mice dramatically alters spontaneous firing rates of locus coeruleus (LC) neurons and the response of the noradrenergic system to chronic opiate exposure, possibly related to the altered regulation of neurotrophic peptides observed. Notably, TgNTRK3 LC neurons showed an increased firing rate in saline-treated conditions and profound abnormalities in their response to met5-enkephalin. Behaviorally, chronic morphine administration induced a significantly increased withdrawal syndrome in TgNTRK3 mice. In conclusion, we show here that the NT-3/TrkC system is an important regulator of neuronal firing in LC and could contribute to the adaptations of the noradrenergic system in response to chronic opiate exposure. Moreover, our results indicate that TrkC is involved in the molecular and cellular changes in noradrenergic neurons underlying both panic attacks and opiate dependence and support a functional endogenous opioid deficit in panic disorder patients.en
dc.description.sponsorshipThis work was funded by the Spanish Ministry of Education and Sciences SAF2007-31093-E, SAF2007-60827, and SAF2008-03612, 2009SGR1313 and Health (PI082038), Fundación Areces, Marató TV3, Phecomp (EU LSHM-CT-2007-037669; 037627-AnEUploidy), Ministerio de Salud y Consumo (RTA G03/005 and PI05/0513, PI082038), University of the Basque Country (1/UPV 0026.327-E-15924/2004 and GIU07/46), Plan Nacional sobre Drogas (PNDMSC 2005) and CIBERER. Patricia Murtra is a scientifi c researcher supported by the Juan de la Cierva program of Ministerio de Ciencia y Tecnología. Teresa Zamalloa was supported by a predoctoral fellowship from the Basque Government.en
dc.language.isoengen
dc.publisherFrontiers Research Fundationen
dc.relationinfo:eu-repo/grantAgreement/MEC/SAF2007-31093-E
dc.relationinfo:eu-repo/grantAgreement/MEC/SAF2007-60827
dc.relationinfo:eu-repo/grantAgreement/MEC/SAF2008-03612
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.subjectTgNTRK3en
dc.subjectNT-3en
dc.subjectTrkCen
dc.subjectBDNFen
dc.subjectTrkBen
dc.subjectpanic disorderen
dc.subjectopiate withdrawalen
dc.subjectlocus coeruleusen
dc.titleIncreased opioid dependence in a mouse model of panic disorderen
dc.typeinfo:eu-repo/semantics/articlees
dc.rights.holderCopyright © 2010 Gallego, Murtra, Zamalloa, Canals, Pineda, Amador- Arjona, Maldonado and Dierssen. This is an open-access article subject to an exclusive license agreement between the authors and the Frontiers Research Foundation, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are credited.es
dc.relation.publisherversionhttp://www.frontiersin.org/behavioral_neuroscience/10.3389/neuro.08.060.2009/abstracten
dc.identifier.doi10.3389/neuro.08.060.2009
dc.departamentoesFarmacologíaes_ES
dc.departamentoeuFarmakologiaes_ES
dc.subject.categoriaBEHAVIORAL NEUROSCIENCE
dc.subject.categoriaNEUROPSYCHOLOGY AND PHYSIOLOGICAL PSYCHOLOGY
dc.subject.categoriaCOGNITIVE NEUROSCIENCE


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record